Biomarkers of peritoneal fibrosis in patients with peritoneal dialysis were investigated by transcriptomics of exfoliated cells and metabolomics of exfoliated cells in peritoneal dialysis
Patients on peritoneal dialysis: a. Age 18-75 years; b. Regular abdominal dialysis due to uremia> 3 months; c. Signed informed consent
Hemodialysis patients: a. Age 18-75 years; b. Due to regular hemodialysis due to uremia> 3 months old, allogeneic kidney transplantation is planned; c. Signed informed consent
Patients with normal renal function: a. Age 18-75 years; b. Proposed elective inguinal hernia repair surgery; c. Signed informed consent.
Patients on peritoneal dialysis: a. History of peritonitis in the past 3 months; b. History of abdominal tumors with peritoneal metastases
Hemodialysis patients: a. Previous abdominal dialysis history; b. History of abdominal tumors with peritoneal metastases Patients with normal renal function: a. History of chronic kidney disease; b. History of abdominal tumors with peritoneal metastases